ALXA: Summary for Alexza Pharmaceuticals, Inc. - Yahoo! Singapore Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 4:44pm SGT - The Singapore stock market closes in 16 minutes.

To create a watchlist or portfolio of shares, Register

FINANCE HOME PAGE

INVESTING

FINANCE NEWS

Alexza Pharmaceuticals Inc. (ALXA)

At 4:59AM SGT: 2.6705 USD 0.00 (0.00%)

MORE ON ALXA

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Alexza Pharmaceuticals, Inc. (NGM:ALXA) Delayed quote data

Last Trade:	2.6705 USD
Trade Time:	4:59AM SGT
Change:	0.00 (0.00%)
Prev Close:	2.6705
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	6.40

Day's Range:	N/A - N/A
52wk Range:	1.40 - 3.25
Volume:	0
Avg Vol (3m):	105,214
Market Cap:	137.84M
P/E (ttm):	N/A
EPS (ttm):	-2.909
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Use Y! Toolbar to track stocks

Add ALXA to Portfolio

Download Data

HEADLINES

•	Coverage initiated on Alexza Pharma by WBB Securities
	Briefing.com (Fri, Jan 29)

•	Alexza Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
	PR Newswire (Fri, Jan 29)

•	Alexza Takes Big Step Forward
	Zacks.com (Fri, Dec 18)

•	Alexza Pharmaceuticals Inc. Announces Submission of AZ-004 NDA Call scheduled for 8:30 am ET today
	CCBN (Tue, Dec 15)

•	JA Solar, Array BioPharma: Early Volume Plays
	at TheStreet.com (Tue, Dec 15)

•	ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events
	EDGAR Online (Tue, Dec 15)

•	Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
	PR Newswire (Tue, Dec 15)

•	Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
	PR Newswire (Fri, Nov 20)

•	ALEXZA PHARMACEUTICALS INC. Financials
	EDGAR Online Financials (Sat, Nov 14)

•	Alexza Pharmaceuticals Inc. Earnings Call scheduled for 5:00 pm ET today
	CCBN (Tue, Nov 10)

•	ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Tue, Nov 10)

More Headlines for ALXA...

ANALYST

EPS Est (next year) (Dec-09) :	-2.48
EPS Est (in 2 years) (Dec-10) :	-0.82
Avg Rec (current)*:	1.8
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Alexza Pharmaceuticals, Inc., a specialty pharmaceutical development stage company, focuses on the research, development, and commercialization of products for the acute treatment of central nervous system conditions.

Full Company Profile

Add to Portfolio

Email to a Friend

•